comparemela.com

Page 8 - Josephine Billie News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Josephine & Billie s

TPCO Holding Corp. (NEO: GRAM.U) (OTCQX: GRAMF), which does business as The Parent Company, has chosen Josephine & Billie s as its first social equity corporate venture fund investment. The investment will help the Los Angeles-based cannabis brand and retail concept to open its first. Read More. Don t Miss Any Updates! News Directly in Your Inbox Subscribe to:

TPCO Holding Co (The Parent Company) social equity fund invests in Josephine & Billie s, a cannabis retailer bringing back the tea pad with a focus on women of color

The Parent Company s social equity fund invests in Josephine & Billie’s, a cannabis retailer bringing back the tea pad with a focus on women of color With The Parent Company’s investment, Josephine & Billie’s is expected to open its first retail location before the end of the year Founded and led by Black women, Josephine & Billie’s was developed to create a welcoming and educational retail experience for women of color and to fill a void within the LA marketplace TPCO Holding Co (The Parent Company) (NEO:GRAM) (OTCQX:GRAMF) has selected Josephine & Billie’s, a Los Angeles-based cannabis brand and retail concept, as its first social equity corporate venture fund investment, the company announced. 

NA Proactive news snapshot: Marrone Bio Innovations Inc, Renforth Resources Inc, Kintara Therapeutics Inc, LexaGene Holdings Inc, Empower Clinics Inc, NexTech AR Solutions Corp, Nano One Materials Corp, Mindset Pharma Inc, Los Andes Copper Ltd, Algernon P

A glance at some of the day s highlights from the Proactive Investors US and Canada newswires Your daily round-up from the world of Proactive Bioasis Technologies Inc (CVE:BTI) (OTCQB:BIOAF) has announced the publication of research validating the ability of its xB3 platform to cross the intact blood-brain barrier (BBB) and its localization in a variety of brain cell types. The company said research shows that the xB3 platform can cross intact BBB and enter intracellular organelles within neurons, glia and microglia in the brain. It said the data from a study published on June 2 in the Frontiers in Neuroscience provide evidence for the utility of xB3 peptide (previously known as MTfpep) as a platform technology for delivery of recombinant and chemically conjugated drug across the BBB. 

Dow fails to eke out a winning day; tech struggles bog down Nasdaq

Dow fails to eke out a winning day; tech struggles bog down Nasdaq The latest set of jobless claims showed that the number of Americans filing for unemployment benefits fell below 400,000 for the first time since the start of the pandemic, while figures from payrolls operator ADP showed that 978,000 new private sector jobs were created in May, ahead of forecasts of 650,000 4:10pm: AMC traders head for the exits The Dow closed Thursday down 23 points to 34,577. The Nasdaq fared worse, losing 142 points, 1%, to 13,615, while the S&P 500 dropped 15 points, 0.4%, to 4,193. Helping the Dow salvage a relatively better day were Merck & Co Inc (NYSE:MRK) and Dow Inc (NYSE:DOW), both of which saw share price gains of more than 2%.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.